AlphaYou
Overview
Smart money at a glance
Filings to Sep 26, 2026Net selling: insiders sold $12.7M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$12.7M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 7 added, 4 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Sep 25- Open
- $220.50
- 52-wk high
- $241.78
- High
- $226.65
- 52-wk low
- $160.60
- Low
- $219.00
- Prev close
- $221.56
- Mkt cap
- $157.31B
- P/E
- 39.5x
- Volume
- 6.20M
- Fwd P/E
- 23.8x
- Beta
- 0.81
- Div yield
- 0.65%
- P/S
- 6.3x
- P/B
- 3.0x
- Profit margin
- +16.0%
- Op margin
- +19.8%
- ROE
- +7.6%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about DHR filings
Are insiders buying or selling Danaher Corporation (DHR) stock?
Net selling: insiders sold $12.7M and bought $0 of DHR stock on the open market in the 90 days to Sep 26, 2026, according to SEC Form 4 filings. The largest was Blair, Rainer (President & CEO), who sold $12.7M. The latest filing was on Aug 24, 2026.
Which members of Congress have traded DHR recently?
None. No member of Congress disclosed a DHR trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this DHR smart-money data?
This summary uses filings available on Sep 26, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (1)
- MI
Millennium
$373.1M
added
Sells/Trims (2)
- TS
Two Sigma
$266.2M
trimmed
- DS
D.E. Shaw
$192.3M
trimmed
What insiders are doing
Sells (2)
- BR
Blair Rainer
$12.7M
sold
- SA
Spoon Alan G
$237K
sold
What Congress is doing
How top traders are positioned
No tracked top-trader positions in DHR right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 5.4% above what analysts expected.
Earnings per share
$1.84 expected
Revenue
No comparable estimate
Reports Oct 20, 2026, in 24 days
Estimates as of Sep 25, 2026
EPS expected
$1.83 to $1.99
Revenue expected
20 analysts
Last 30 days
Analysts cutting estimates
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $6.05B | $6.84B | $5.95B | $6.26B |
| Cost of what it sold | $2.53B | $2.87B | $2.36B | $2.65B |
| Gross profit | $3.52B | $3.97B | $3.59B | $3.61B |
| What it spent | ||||
| Research and development | $378.0M | $438.0M | $387.0M | $412.0M |
| Sales and admin | $1.99B | $2.03B | $1.86B | $2.07B |
| Total operating expenses | $2.37B | $2.46B | $2.25B | $2.48B |
| What was left | ||||
| Operating profit | $1.15B | $1.50B | $1.34B | $1.13B |
| Interest on debt | $67.0M | $55.0M | $63.0M | $107.0M |
| Profit before tax | $1.08B | $1.37B | $1.24B | $1.08B |
| Tax | $168.0M | $176.0M | $206.0M | $208.0M |
| Net profit | $908.0M | $1.20B | $1.03B | $870.0M |
| EBITDA | $1.76B | $2.05B | $1.49B | $1.84B |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Bio-Techne (TECH) Opens Düsseldorf Hub As Fair Value Questions Come Into Focus
NeutralSep 23If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth Now
NeutralSep 23Is Revvity Stock Outperforming the Dow?
Leans bearishSep 23Is Revvity Stock Outperforming the Dow?
Leans bearishSep 23Danaher Corp. stock holds near USD 200 before October results
NeutralSep 23Danaher stock rises 0.16 percent ahead of the open
Leans bullishSep 23Danaher to webcast Q3 2026 earnings call on Oct 21, discussing financial results and future outlook.
NeutralSep 22Danaher will webcast its next financial update Oct. 21
Leans bullishSep 22
Macro
31 macro signals shaping DHR right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results